chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (Minor rash on her arms, hand, legs, neck, back and torso) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Apr-2021, the patient experienced RASH (Minor rash on her arms, hand, legs, neck, back and torso). The patient was treated with HYDROCORTISONE (topical) for Rash, at an unspecified dose and frequency and ACRIVASTINE (BENADRYL ALLERGY RELIEF) (oral) for Rash, at an unspecified dose and frequency. At the time of the report, RASH (Minor rash on her arms, hand, legs, neck, back and torso) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.
COVID-19; COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm and on 23Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 10Dec2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Pfizer dose =1, Pfizer Vaccine dose =2, Moderna Vaccine dose number=3" (unspecified if ongoing), notes: Pfizer dose =1, Pfizer Vaccine dose =2, Moderna Vaccine dose number=3. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 2022, outcome "unknown", COVID-19 (medically significant) with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (May2022) Positive; (2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
NO ADVERSE EVENTS  OCCURRED. PATIENT RECEIVED THE BOOSTER DOSE OF PFIZER COVID-19 VACCINE BUT WAS INELIGIBLE TO DO SO BASED ON HIS AGE
A report has been received from a Health Professional concerning a female patient. The patient's medical history, concurrent diseases and concomitant medications were not reported. On 27-Jan-2014 the patient received nasal FLUMIST (intranasal), but the vaccine was expired on 20-Jan-2014. At the time of reporting, the outcome of the event of administration of expired dose was unknown. The report was considered to be non-serious by the reporter.
Couldn't Breath, Died due to Blood Clots on Lungs, Bilateral Pulmonary Embolism, Bleeding on the Brain.
Immediately following administration of vaccine the pt lost consciousness for approx ? after had a small seizure  ?.
Case had COVID vaccines x 2. Last vaccine given at HCF on 2/12/21. Case presented to ED on 7/24/2021 with covid like symptoms. Postitive test for COVID 19 and was admitted to another HCF on 7/24/2021. He expired at that facility on 8/4/21.
ErythemaMultiform & Injection site on right arm has been red, hot, and painful for 3 days post injection
Pt recv vax on 4/16/98; on 4/29/98 pt exp itchy rash on face &trunk, fever (99.6F)
Covid19 breakthrough.  1st Vaccine received on 09/09/2021.  20 y/o female presented to ED with cough, worsening SOB, fever, congestion,myalagis, nausea/vomiting x4-5 days.  O2sat 84% on room air, T-102.2, tachycardic, tachypneic. Initially placed on 15L NRB mask but ultimately moved to BIPAP.  CXR with haxy and linear opacities R/L lung bases.  Started on IV Steroids/IV abx and Remdesivir.
Redness, swelling at injection site to left lateral thigh. Treatment perscription for child Ibuprofen 6mls every 6 to 8 hrs as need for pain.
No symptoms were reported by any of the patients; Improperly stored vaccines administered; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent conditions, concomitant therapies and previous drug reactions or allergies was not provided.   On 13-MAY-2021, the patient was vaccinated with one improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (formulation, strength, exact dose, vaccination scheme frequency, route of administration, and anatomical location were not reported; lot number 1687292, which have been verified to be a valid lot number, expiration date reported and upon internal validation established as 25-AUG-2022) as prophylaxis (product storage error).  The administered dose of the vaccine experienced a temperature excursion of 50 degrees Fahrenheit (F) for 10 minutes, as recorded by a data logger. There was no previous temperature excursion reported. No adverse events were reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); devicelotnumber: 1687292; expirationdate: 25-AUG-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2105USA003873: US-009507513-2105USA003871: US-009507513-2105USA003867: US-009507513-2105USA003867:
No adverse effects reported; an unspecified 19 year old patient was inadvertently administered a pediatric dose, 0.5 ml, of VAQTA; This spontaneous report was received from a nurse practicioner referring to a 19 year old patient of unknown gender.  The patient's concurrent conditions, past medical history and concomitant medications were not reported.  On 07-AUG-2019, the patient was vaccinated with a pediatric dose (0.5 ml) of hepatitis a vaccine, inactivated(VAQTA) lot # S007769 and expiration date 24-JUL-2020 (frequency and route were not provided) for prophylaxis (incorrect dose administered). No adverse events were reported.
swollen lymph nodes; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age (reported as "Age: 46; Unit: Unknown") received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if it was normal to have swollen lymph nodes after getting the 1st dose of the COVID 19 vaccine. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were reported. On 07-AUG-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (lot # M017983, expiration date 30-MAY-2018) (dosage, frequency and route were not reported) for prophylaxis (incorrect product storage). No adverse effect reported. The vaccine was stored at a temperature from 0 degree centigrade to 1 degree centigrade for 1 hour 45 minutes and -1 degree centigrade or colder (-6.09 degree centigrade) for 9 hours 45 minutes. There was no previous temperature excursion. Data logger was involved. No product quality complaint was involved. No further information was provided.  This is one of several reports received from same reporter.; Sender's Comments: US-009507513-1708USA005043:
aches, exhaustion, fever (101) that wont go down with ibuprofin (200).  Onset ~ 6 hours after dose. can look up extra details on  accine lot, route etc. but i dont have the card handy at the moment. can also give extra info on  thyroid and hormone levels if its useful.
has a strong feeling of nausea but has not vomited yet; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (has a strong feeling of nausea but has not vomited yet) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Paralysis in 2019 and Infection (infection of 2 legs) in 2019. Concurrent medical conditions included Blood pressure high. Concomitant products included METFORMIN for Diabetes mellitus management.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced NAUSEA (has a strong feeling of nausea but has not vomited yet). At the time of the report, NAUSEA (has a strong feeling of nausea but has not vomited yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient does physical therapy. Other relevant medication history included insulin and metformin for blood sugar level control for 10 years. No treatment information was provided.
Severe pain in shoulder. Limited range of motion.  Waiting on MRI result. Started PT.
Got sick two days after the second day, just sick for one day. Then after that i have had pain and weakness in my left arm. It does not seam to want to go away.
Received Pneumovax on 11/10/99.  Began with hives, angioedema 11/15/99.  Was also on Ciproflacin from 11/10/99. Pt has had an identical reaction 9/14/88, 5 days after receiving Pneumovax.  Given Zyrtec, Kenalog.
"I" have been getting consistent headaches that "I" have never experienced before.; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration on 02Apr2021 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The concomitant medications were not reported. On 03Apr2021, after getting the second dose of the Pfizer vaccine the patient had been getting consistent headaches that she had never experienced before. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event consistent headaches was unknown at the time of this report.    No follow-up attempts are possible. No further information is expected.
Patient left voicemail stating she had a small rash on her arm and soreness after receiving the vaccine.
A week after receiving my fourth dose of Moderna, I began experiencing symptoms of a kidney stone. Beginning around 09/21/2022, the pain was really bad by 09/24/2022. I was able to see a urologist on 09/29/2022. I did have to have some kidney stones removed 3 months after my first dose of my COVID-19 vaccine in 2021 as well as after my third dose in 2022. Before beginning my COVID-19 vaccines, I had not had a kidney stone since 2009. After seeing my urologist, she prescribed a medication, and I had an ultrasound of my kidney and bladder where they discovered a kidney stone in my right kidney. She advised to continue drinking water and if it became symptomatic, they would do a CAT scan and decide on further treatment but hasn't been bothering me since I began the medication.
Day after vaccine patient started getting body tremors from her feet to her head.  Tuesday - Friday she got about two per day then they increased to three and now dour per day.  On Friday March 12th we went to see her primary care physician who instructed us to see a Neurologist whom we are seeing today.
No other adverse events reported; Caller reports that improperly stored vaccines were administered. No other adverse events reported. No product quality complaints. No further information.          ?    Names of vaccines involved (including lot/exp) GARDASIL 9 (lot: U031056 exp: 06; This spontaneous report has been received from an administrator, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.   On 09-MAR-2023, the patient was vaccinated with an improperly storage dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) injection, as prophylaxis (lot number: U031056, which was determined to be valid as syringe, with an expiration date on 16-JUN-2024) (strength, dose, scheme, route and anatomical location of administration were not reported).  The administered dose underwent a temperature excursion of -40 degrees Fahrenheit (F), for 70 hours and 5 minutes. No previous temperature excursion was reported. No additional adverse event was reported.
Sore red spots on left side of abdomen and back.  Diagnosed several days later with shingles.
From 1/21/22 onwards I had headaches and tiredness . By 3/22 I felt twinges occasionally in my chest. 3/25/22 I was not I BLT rubbing my chest and had Drs appointment on 3/27/22. It got worse daily. By 3/31/22 around midnight I had a lot of pain and pressure and 4/1/22 shortness of breath and major pain. Went to urgent care and EKG was fine, chest X-ray was fine and troponen levels were elevated. Sent to Medical Center E.R. Was admitted and given blood thinner shots to stomach and a pill for heart inflammation in case it was pleuritus. More EKG and bloodwork done . Normal held for heart ultrasound and stress test. Heart ultrasound normal stress test positive. Did angiogram and was told by cardiologist it was beautiful no blocks, plaque nothing until he got to my LAD?Widow MAKER? are teary it was over 95%blocked with a clot. Stent put in.
pt recv vax 1NOV96 & 13NOV96 it was reported that pt could not bear weight on lt leg;x-ray results did not determine a dx;16DEC96 pt reportedly had a sed rate of 48;dx JRA;
Have had previous high blood pressure condition, but it was under control. Noticed after the 1st of the year that it was elevated to 160. Went to doctor and had Lisinopril blood pressure medication dose increased, doctor left the practice. I'm seeing a Cardiologist now and he added Carvedilol Beta Blocker and reduced my Lisinopril dosage.
The injection site got really red, swollen, super hard and hot to the touch. I felt weak, tired, dizzy, nauseous.
Headache 7/10, Temp 99.8F, light sensitivity,  myalgia
pt recvd inject 11MAY & on 12MAY arm was real tender & stiff felt like a real bad bruies; 13MAY notice swelling around inject site & lt hand; still very tender & stiff, rash over for arm of lt arm; redness around site, very warm to touch;
Red spotty rash. Varying size of red dots. Pin size to Pea size. Light and dark red. Mostly on the back and spotty on the rest of the body. Slightly raised and clear separation between each spot. The child is very drowsy. At he time of this report he has no fever. The child is also taking Zyrtec for seasonal allergy relief. Called the Dr. and she instructed to monitor closely and if a fever over 103 degrees occurs get to ER.
Bruising at vacccine injection shot site (left arm). No treatment has been performed. As of today, bruising is still there however associated pain has subsided. In addition to this report, bruising (side effect) has been shown and reported to the pharmacy manager.
Knot/bruise on right anterior thigh where DTaP given approximately 1 inch diameter.
Patient is a 70 year old male with RCC s/p left nephrectomy (2018), marginal zone lymphoma (2018) s/p 6 cycles chemotherapy, diabetes, HTN, CAD, esophageal strictures with multiple dilations, esophageal perforation causing constrictive carditis necessitating a cardiac window, and recurrent RCC from lymph node biopsy now on Cabozantinib who presents to the ED after one day nausea and vomiting. Patient reports he is doing well until yesterday when he begins to have some abdominal pain on his left side radiating into his back. He has chronic back pain but feels like this pain is different. He did tolerate diet yesterday. This morning, he had 3 vomiting episode and watery bowel movement. He also endorses burning pain when urinating today. He states that he had several UTIs previously. Patient has chronic productive cough from COPD history but denies increase or worsening of cough.   In the ED, he was found to be tachycardic HR 106 and febrile T 38.4. Labs notable for Hgb 11.1, lactic acid 1.8, and mild transaminitis (chronic). UA showed WCC, blood, leukocyte, and RBC. Patient was given 1L IVF and started on vanc and meropenem. CXR was unremarkable. Troponin negative. Covid from RPP came back positive. Patient stated that he had Covid previously in Jan 2021 and had both Covid vaccines on January.   Of note, patient was diagnosed with marginal zone lymphoma on Jan 2019 and was on 6 cycles of bendamustine and rituximab previously in 2019, with current plan of observation. He was also diagnosed with left cell renal carcinoma on Sept 2018 s/p L nephrectomy 2018, SBRT. Metastatic disease was confirmed on Jan 2020 and patient is currently on cabozantinib. He has notable side effects while on treatment including neuropathy and thrombocytopenia.
The patient noticed a red patch on 10/28/14. Little warm, but no itching or pain. Resolved next day.
SITE PAIN, SWELLING AND TENDERNESS FIRST. 2-3 DAYS LATER FEVER, FATIGUE, DIZZINESS, HEADACHES, NAUSEA, INTERMITTENT HEART RACING, AND WEAKNESS.  SEEN PCP 03/30/21.
She got her vaccine, first she had a little sore arm on the left.  Then she started getting headaches.  On Tuesday afternoon she started getting a light fever, chills, sweating, no appetite, diarrhea, and also her heart was racing high.  Body aches all over.  She called her doctor and she suggested for her to take Tylenol and to drink plenty of fluids and to eat dry toast as she was not able to hold anything down.  She did not like the rapid heart beat.  She told her if her heart beat to go to the ER.  She had COVID in December and was in the hospital for 3 weeks and had pneumonia and other symptoms and recovered from that,  and then put in rehab center for 2 more months from 1/1/21 to 3/3/21.  She is still recovering, does get out of breath easily and is home bound and has to use oxygen when she moves around.  She was not on oxygen before having COVID.    She checks her heart rate and oxygen level every day since having the COVID and is recovered from the vaccine.  She does FU with her doctor weekly due to the COVID virus.
Very aggressive while receiving vaccinations, appeared to get "limp" after while crying. Possible breath holding spell.
Pt. states (L) arm started hurting one hr. after she received injection. States by evening she could barely move her arm. C/o pain in (L) shoulder and states occasionally radiates to elbow. Denies external redness or swelling. Has seen chiropractor and family physician.
"felt funny as soon as medicine went in" dizzy, feel like throat closing, but could eat a power bar Taken to exam room, vitals taken and are stable, no SOB, slight nausea, no LOC
On 3/2 I develop headache, body ache, and low grade fever. On 3/9 I developed blotchy skin on my legs and my hip joints felt like they were on fire. My thigh and groin areas were sensitive to touch. On 3/10 I had a blistering rash develop in the groin area on the right side .  On 3/12 I was diagnosed with shingles and was prescribed medication; Acyclovir 800 miligram tablets by mouth, 5 tablets a day for 7 days and Temazepam 15 milligram capsules for 10 days. I completed the subscriptions on 3/21. Should I get my scheduled second Covid vaccine shot on 3/31 given the scenario described above?
Severe vertigo; pressure in the ears; eye nystagmus drastically worsened; Strong intense pressure in the head (not a headache); Fatigue
I was advised by Dr. of the CDC to report this as an administration error.  My grandson was mistakenly given the nasal flu vaccine with live cultures, even though only the flu shot without the live culture is approved for children under the age of 24 months.  The mistake was caught after the vaccine was administered in one nostril only.  The healthcare facility then contacted the vaccine manufacturer and decided that the patient should also be given the flu shot. Approximately 10 days later the child became ill and he has an appointment with a physician on Monday, October 13, 2014.
no adverse effects; patient received dose of PNEUMOVAX 23 that was improperly stored; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. There was no information about the patient's pertinent medical history, concomitant therapies or drug reactions and allergies provided. On 27-SEP-2019, the patient was vaccinated with improperly stored dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) lot # S012246, expiration date 10-FEB-2021 (exact dose, injection site and route of administration were not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 68 degrees Fahrenheit for 8 hours. The digital data logger was involved in recording the temperature excursion details. Administered dose of vaccine experienced the previous temperature excursion of 57 degrees Fahrenheit for 2 hours. There was no adverse effects reported.
idk; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15May2021 at 15:30 (at the age of 15-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any medications within two weeks of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 15May2021, the patient reported that he experienced "idk". On 15May2021, the patient underwent a nasal swab test, the results of which were not known. It was unknown whether any therapeutic measures were taken as a result of the event. The clinical outcome of the event "idk" was unknown at the time of this report.   No follow up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a pharmacist refers to a patient of unknown gender who was less than 50 years old. Pertinent medical history and drug reactions/allergies were not reported. On 05-SEP-2013, the patient was vaccinated with PNEUMOVAX23 (dose and route were not reported). Concomitant therapy was not reported. The patient would additionally receive the ZOSTAVAX on 05-SEP-2013 at the pharmacy. No adverse effects reported.  Additional information has been requested.